Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Wolfe Research
November 1, 2019 8:10 AM
Wolfe Research analyst Tim Anderson raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $57.00) while maintaining a Outperform rating.
